Revolution Medicines, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDRevolution Medicines, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 97), indicating clear outperformance against the broad market. Earnings contraction of 103% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $169.27 | +12.52% | ABOVE |
| 50 SMA | $156.58 | +21.63% | ABOVE |
| 100 SMA | $131.68 | +44.64% | ABOVE |
| 150 SMA | $118.54 | +60.67% | ABOVE |
| 200 SMA | $102.84 | +85.19% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is RVMD in an uptrend right now?
RVMD has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, RVMD is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is RVMD overbought or oversold?
RVMD's RSI (14) is 73. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is RVMD outperforming the market?
RVMD has a Relative Strength (RS) Rating of 97 out of 99. Yes, RVMD is a market leader, outperforming 97% of all stocks over the past 12 months.
Where is RVMD in its 52-week range?
RVMD is trading at $190.46, which is 98% of its 52-week high ($193.69) and 98% above its 52-week low ($34.00).
How volatile is RVMD?
RVMD has a Beta of 1.22 and 52-week volatility of 67%. It's more volatile than the S&P 500 - expect bigger swings.